BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
(+34%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
14.78%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
149
New
11
Increased
79
Reduced
34
Closed
11
Top Buys
| 1 |
Abbott
ABT
|
$14.5M |
| 2 |
Pacific Biosciences
PACB
|
$13.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 4 |
CareDx
CDNA
|
$9.72M |
| 5 |
Medtronic
MDT
|
$9.3M |
Top Sells
| 1 |
DexCom
DXCM
|
$28.5M |
| 2 |
Bausch Health
BHC
|
$3.02M |
| 3 |
Amgen
AMGN
|
$2.27M |
| 4 |
Gilead Sciences
GILD
|
$1.76M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 93.18% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0.34% |
| 4 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Henry Schein
HSIC
$8.14B
| $4.37M | 0.28% |
65,494
| – | – |
|
|
HZNP
77
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.34M | 0.28% |
221,678
+30,100
| +16% | +$589K |
|
|
ESRX
78
DELISTED
Express Scripts Holding Company
ESRX
| $4.23M | 0.27% |
44,500
| – | – |
|
79
Dentsply Sirona
XRAY
$2.77B
| $4.19M | 0.27% |
110,878
+35,785
| +48% | +$1.35M |
|
80
Tandem Diabetes Care
TNDM
$834M
| $4.16M | 0.26% |
97,195
-16,811
| -15% | -$720K |
|
81
Inspire Medical Systems
INSP
$2.53B
| $3.82M | 0.24% |
90,696
+42,743
| +89% | +$1.8M |
|
|
CERN
82
DELISTED
Cerner Corp
CERN
| $3.81M | 0.24% |
59,146
+1,246
| +2% | +$80.3K |
|
|
ENDP
83
DELISTED
Endo International plc
ENDP
| $3.66M | 0.23% |
217,392
+118,300
| +119% | +$1.99M |
|
|
SGEN
84
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.62M | 0.23% |
46,950
-2,550
| -5% | -$197K |
|
85
Incyte
INCY
$17B
| $3.62M | 0.23% |
52,350
-2,500
| -5% | -$173K |
|
|
OXFD
86
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.6M | 0.23% |
221,837
+111,176
| +100% | +$1.8M |
|
87
Neuronetics
STIM
$216M
| $3.59M | 0.23% |
111,907
+61,907
| +124% | +$1.98M |
|
88
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $3.56M | 0.23% |
215,935
+18,100
| +9% | +$299K |
|
89
Veeva Systems
VEEV
$44.4B
| $3.56M | 0.23% |
32,691
+22,395
| +218% | +$2.44M |
|
90
iShares Biotechnology ETF
IBB
$5.68B
| $3.41M | 0.22% |
+28,000
| New | +$3.41M |
|
91
Nektar Therapeutics
NKTR
$543M
| $3.38M | 0.21% |
3,701
+1,401
| +61% | +$1.28M |
|
|
AMED
92
DELISTED
Amedisys
AMED
| $3.15M | 0.2% |
+25,204
| New | +$3.15M |
|
93
Ligand Pharmaceuticals
LGND
$3.25B
| $3.09M | 0.2% |
18,066
-1,282
| -7% | -$220K |
|
|
ICPT
94
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.05M | 0.19% |
24,148
-500
| -2% | -$63.2K |
|
|
MTLS
95
Materialise
MTLS
$291M
| $2.91M | 0.18% |
210,731
+171,402
| +436% | +$2.37M |
|
96
Penumbra
PEN
$10.5B
| $2.87M | 0.18% |
19,142
+5,115
| +36% | +$766K |
|
97
Johnson & Johnson
JNJ
$429B
| $2.76M | 0.18% |
20,000
| – | – |
|
|
MDSO
98
DELISTED
Medidata Solutions, Inc.
MDSO
| $2.71M | 0.17% |
36,907
+32,258
| +694% | +$2.37M |
|
|
AGN
99
DELISTED
Allergan plc
AGN
| $2.48M | 0.16% |
13,000
+3,000
| +30% | +$571K |
|
100
Ultragenyx Pharmaceutical
RARE
$3.04B
| $2.43M | 0.15% |
31,850
-7,300
| -19% | -$557K |
|